The CEO of Novo Nordisk was questioned about the high cost in the U.S. of Wegovy and Ozempic, the wildly popular diabetes and ...

With Medicare now covering semaglutide for people with obesity and cardiovascular disease who don't have diabetes, a study looks at who that might include, depending on what cutoffs prescription plans ...

Obesity and related diseases, including cardiovascular disease, hypertension, and type 2 diabetes, are leading causes of death in the U.S. While nearly half of American adults today are interested in ...

Ozempic, for type 2 diabetes, has a U.S. list price of $969 a month, while Wegovy, the weight loss medication, has a list ...

Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of ...

In May, Lizzo shed some light on her weight loss journey. In a video posted to TikTok, she said she was 'not trying to escape fatness,' and that she 'started working out for mental health,' which led ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

The efficacy of weight loss strategies has long been debated, but insights suggest nutrition plays a more important role than ...

The much-hyped AI products like ChatGPT may provide medical doctors and health care professionals with information that can ...

Businesses can take proactive steps now to best position themselves for a competitive advantage in the face of the seismic shift these medications will have on the industry.

Due to a Wegovy shortage coupled with Ozempic’s weight loss effects going viral on social media, people without type 2 diabetes have begun using Ozempic off-label for weight loss. In this ...